Course of Renal Injury in the Mpv17-Deficient Transgenic Mouse

Abstract

Abstract. The mutant Mpv17 mouse is a transgenic strain that fails to express a protein that is normally expressed in the kidney and that is associated with peroxisomes. The present studies provide a quantitative examination of renal function and structure in this strain compared to its control CFW strain. By 52 wk of age, the mutant strain developed proteinuria (urinary protein to creatinine ratio: 25 ± 14 versus 3 ± 1, mutant versus control), albuminuria (urinary albumin to creatinine ratio: 23 ± 15 versus 0.1 ± 0.1, mutant versus control), and hypoalbuminemia (2.1 ± 0.4 versus 2.5 ± 0.2 G/dl, mutant versus control), but without arterial hypertension or major reduction in filtration (serum creatinine 0.14 ± 0.04 versus 0.18 ± 0.12 mg/dl, mutant versus control). The Mpv17 glomeruli were enlarged (0.98 ± 0.12 versus 0.52 ± 0.02 μm3 × 106, mutant versus control). Glomerular sclerosis became widespread (95 ± 3 versus 23 ± 32%, mutant versus control) and was preceded by mesangiolysis and microaneurysms. Tubulointerstitial disease was conspicuous by its absence. The intrarenal vasculature was normal in the mutant mice. Electron microscopy demonstrated focal foot process fusion and mesangiolysis. Thus, this mutant strain of mouse develops proteinuria and a distinct glomerulopathy including mesangiolysis but little interstitial injury all due to the loss of expression of a single gene.